郭博慧, 李毅, 李向东. 地黄叶总苷联合雷公藤多苷对膜性肾病患者的疗效及预后影响[J]. 临床肾脏病杂志, 2019, 19(1): 54-57,69. DOI: 10.3969/j.issn.1671-2390.2019.01.011
    引用本文: 郭博慧, 李毅, 李向东. 地黄叶总苷联合雷公藤多苷对膜性肾病患者的疗效及预后影响[J]. 临床肾脏病杂志, 2019, 19(1): 54-57,69. DOI: 10.3969/j.issn.1671-2390.2019.01.011
    GUO Bo-hui, LI Yi, LI Xiang-dong. Effectiveness of rehmannia glutinosa combined with tripterygium glycosides in treatment of idiopathic membranous nephropathy and prognostic analysis[J]. Journal of Clinical Nephrology, 2019, 19(1): 54-57,69. DOI: 10.3969/j.issn.1671-2390.2019.01.011
    Citation: GUO Bo-hui, LI Yi, LI Xiang-dong. Effectiveness of rehmannia glutinosa combined with tripterygium glycosides in treatment of idiopathic membranous nephropathy and prognostic analysis[J]. Journal of Clinical Nephrology, 2019, 19(1): 54-57,69. DOI: 10.3969/j.issn.1671-2390.2019.01.011

    地黄叶总苷联合雷公藤多苷对膜性肾病患者的疗效及预后影响

    Effectiveness of rehmannia glutinosa combined with tripterygium glycosides in treatment of idiopathic membranous nephropathy and prognostic analysis

    • 摘要: 目的 探讨地黄叶总苷联合雷公藤多苷对膜性肾病患者的疗效及对预后影响。方法 选取2016年1月至2017年12月西安交通大学附属三二O一医院收治的76例膜性肾病患者,采用回顾性分析的方法,把入选病例分为观察组和对照组,每组38例。对照组采用雷公藤多苷治疗,观察组采用地黄叶总苷联合雷公藤多苷方案治疗。比较2组患者的疗效、不良反应以及预后情况。结果 观察组的治疗总有效率为84.21%(32/38),对照组为57.89%(22/38),观察组的总有效率高于对照组,差异有统计学意义(P<0.05);治疗前,两组患者的血清白蛋白、尿蛋白定量、血白细胞、胆固醇、谷丙转氨酶、肌酐水平相比,差异无显著性(P>0.05)。治疗后,观察组血清白蛋白较对照组明显上升(P<0.05),患者尿蛋白定量、胆固醇及血白细胞较对照组明显下降(P<0.05),而谷丙转氨酶和肌酐与对照组相比未见明显变化(P>0.05)。利用Cox回归分析,发现高血压、高血肌酐、肾小球硬化、大量蛋白尿是影响膜性肾病患者预后的主要因素(P<0.05),对于不存在这些症状的患者,观察组总不良反应发生率低于对照组(7.89% vs 26.32%),差异有显著性(P<0.05)。结论 地黄叶总苷联合雷公藤多苷对膜性肾病患者的疗效相比单独使用雷公藤多苷较好,不良反应更少,对不存在高血压、高血肌酐、肾小球硬化、大量蛋白尿的患者,该方案治疗的预后较好,值得进一步临床研究探讨。

       

      Abstract: Objective To investigate the effectiveness of total glucosides of Tripterygium Wilfordii and Tripterygium Wilfordii Hook in the treatment of membranous nephropathy and the prognosis.Methods 76 patients with membranous nephropathy treated in our hospital in January 2016-2017 December were selected to be divided into the observation group and the control group,with 38 cases in each group.The control group was treated with tripterygium glycosides,and the observation group was treated with total glucosides of Tripterygium wilfordii combined with tripterygium glycosides.The efficacy,adverse reactions and prognosis of the 2 groups were compared.Results The total effective rate in the observation group and control group was 84.21% (32/38) and 57.89% (22/38) respectively (P<0.05). Before treatment, the levels of serum albumin, urine protein, blood leukocyte, cholesterol, alanine aminotransferase and creatinine levels were comparable between the two groups (P>0.05). After treatment, the serum albumin in the observation group was significantly higher than that in the control group (P<0.05). The urine protein quantity, cholesterol and blood leukocyte were significantly lower in the observation group than those in the control group (P<0.05), while the alanine aminotransferase and creatinine showed no significant difference between two groups (P>0.05). The results of Cox regression analysis revealed that hypertension, hyperanic creatinine, glomerular sclerosis and massive proteinuria were the main factors affecting the prognosis of patients with membranous nephropathy (P < 0.05). In the absence of these symptoms, the incidence of total adverse reactions in the observation group was significantly lower than that in the control group (7.89% vs 26.32%) (P<0.05).Conclusions The effectiveness of total glycosides of Tripterygium wilfordii combined with tripterygium glycosides in the treatment of membranous nephropathy is better than that of Tripterygium wilfordii alone, with less adverse reactions. The prognosis of the treatment is better for the patients having no hypertension, high blood creatinine, glomerulosclerosis and massive proteinuria.

       

    /

    返回文章
    返回